Biogen Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Revenue	9,836	10,173	10,982	13,445	14,378	Upgrade
Revenue Growth (YoY)	-3.32%	-7.36%	-18.32%	-6.49%	6.88%	Upgrade
Cost of Revenue	2,533	2,278	2,110	1,805	1,955	Upgrade
Gross Profit	7,302	7,895	8,872	11,639	12,423	Upgrade
Selling, General & Admin	2,550	2,404	2,674	2,505	2,375	Upgrade
Research & Development	2,462	2,231	2,501	3,991	2,281	Upgrade
Other Operating Expenses	993.7	-331.4	1,951	96.5	724.6	Upgrade
Operating Expenses	6,005	4,303	7,127	6,592	5,380	Upgrade
Operating Income	1,297	3,592	1,745	5,048	7,043	Upgrade
Other Expense / Income	0.4	-87.9	136.6	54.6	-3.9	Upgrade
Pretax Income	1,296	3,680	1,609	4,993	7,047	Upgrade
Income Tax	135.3	632.8	52.5	992.3	1,158	Upgrade
Net Income	1,161	3,047	1,556	4,001	5,889	Upgrade
Net Income Growth	-61.89%	95.80%	-61.10%	-32.06%	32.90%	Upgrade
Shares Outstanding (Basic)	145	145	149	161	187	Upgrade
Shares Outstanding (Diluted)	146	146	150	161	187	Upgrade
Shares Change	-0.27%	-2.41%	-7.25%	-13.93%	-8.72%	Upgrade
EPS (Basic)	8.02	20.96	10.44	24.86	31.47	Upgrade
EPS (Diluted)	7.97	20.87	10.40	24.80	31.42	Upgrade
EPS Growth	-61.81%	100.67%	-58.06%	-21.07%	45.60%	Upgrade
Free Cash Flow	1,236	1,724	3,363	3,753	6,409	Upgrade
Free Cash Flow Per Share	8.54	11.86	22.55	23.32	34.26	Upgrade
Gross Margin	74.24%	77.61%	80.79%	86.57%	86.40%	Upgrade
Operating Margin	13.18%	35.31%	15.89%	37.54%	48.98%	Upgrade
Profit Margin	11.81%	29.95%	14.17%	29.76%	40.96%	Upgrade
Free Cash Flow Margin	12.56%	16.94%	30.62%	27.91%	44.58%	Upgrade
Effective Tax Rate	10.44%	17.20%	3.26%	19.87%	16.43%	Upgrade
EBITDA	1,791	4,318	2,726	5,660	7,727	Upgrade
EBITDA Margin	18.21%	42.44%	24.82%	42.10%	53.74%	Upgrade
Depreciation & Amortization	494.8	638	1,117	666.9	680.6	Upgrade
EBIT	1,296	3,680	1,609	4,993	7,047	Upgrade
EBIT Margin	13.18%	36.17%	14.65%	37.14%	49.01%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).